Technical Analysis for ANGO - AngioDynamics, Inc.
|Grade||Last Price||% Change||Price Change|
ANGO closed up 0.17 percent on Friday, September 22, 2017, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Sep 28
Trend Table & Recent Alerts
|See historical ANGO trend table...|
|Date||Alert Name||Type||% Chg|
|Sep 22||NR7||Range Contraction||0.00%|
|Sep 22||Narrow Range Bar||Range Contraction||0.00%|
|Sep 22||MACD Bearish Signal Line Cross||Bearish||0.00%|
|Sep 20||NR7||Range Contraction||-0.50%|
|Sep 14||Hammer Candlestick||Bullish||-0.56%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Is ANGO a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ANGO news...
|52 Week High||18.35|
|52 Week Low||14.8|
|200-Day Moving Average||16.4497|
|50-Day Moving Average||16.8396|
|20-Day Moving Average||17.4775|
|10-Day Moving Average||17.911|
|Average True Range||0.3931|
|Chandelier Exit (Long, 3 ATRs)||17.1707|
|Chandelier Exit (Short, 3 ATRs)||17.4693|
|Upper Bollinger Band||18.5584|
|Lower Bollinger Band||16.3966|
|Percent B (%b)||0.68|
|MACD Signal Line||0.3405|